United Therapeutics (UTHR) Misses Q4 EPS by 49c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $512.70 +0.45%
Revenue Growth %: -1.2%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
PMCB, PLCE, DOMO, More
Revenue Growth %: -1.2%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $6.19, $0.49 worse than the analyst estimate of $6.68. Revenue for the quarter came in at $735.9 million versus the consensus estimate of $739.92 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pizza Hut CEO Aaron Powell resigns
- NVIDIA (NVDA) Said To Near $14 bln Deal For Hugging Face This Week - Bloomberg
- iMetal Resources names mining veteran Michel Dufresne to its board
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
